Tatosian, D. A., Guo, Y., Schaeffer, A. K., Gaibu, N., Popa, S., Stoch, A., . . . Kauh, E. A. (2013). Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin. Springer Healthcare.
Citação norma ChicagoTatosian, Daniel A., Ying Guo, Andrea K. Schaeffer, Natalia Gaibu, Serghei Popa, Aubrey Stoch, Ronald B. Langdon, and Eunkyung A. Kauh. Dipeptidyl Peptidase-4 Inhibition in Patients With Type 2 Diabetes Treated With Saxagliptin, Sitagliptin, or Vildagliptin. Springer Healthcare, 2013.
Citação norma MLATatosian, Daniel A., et al. Dipeptidyl Peptidase-4 Inhibition in Patients With Type 2 Diabetes Treated With Saxagliptin, Sitagliptin, or Vildagliptin. Springer Healthcare, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.